|
|
|
LifeScienceHistory.com - Check us out on Instagram
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AveXis, Inc.
| AveXis, Inc. 2275 Half Day Road, Suite 160 Bannockburn, IL 60015 | |
| | Phone: | (844) 428-3947 | Year Established: | 2010 | Ticker: | NVS | Exchange: | NYSE | Main Contact: | Sean P. Nolan, President & CEO | | Other Contacts: | Allan A. Kaspar, Ph.D., M.B.A., VP, R&D RICK MODI, Senior VP & CBO Sukumar Nagendran, M.D., Senior VP & CMO
| | Company Description | AveXis,a Novartis company, is a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases. The company’s initial proprietary gene therapy product candidate, AVXS-101, is in an ongoing Phase 1 clinical trial for the treatment of SMA Type 1. | |
|
|
|
|
|